SEARCH

SEARCH BY CITATION

Keywords:

  • chronic granulomatous disease;
  • CYBA;
  • mutation analysis;
  • p22-phox expression;
  • genotype–phenotype correlation

Chronic granulomatous disease (CGD) is a disorder caused by defects in the NADPH oxidase responsible for superoxide generation in phagocytes. Cytochrome b558, an essential component of this enzyme, is a heterodimer formed by a 91 kDa glycoprotein (gp91-phox) and a 22 kDa polypeptide (p22-phox). Mutations in the p22-phox gene (CYBA) locus in 16q24 result in one of the rare autosomal recessive forms of CGD. We performed mutation analysis in three female CGD patients suspected of having this form of the disease and found two novel mutations in CYBA. Whereas patient 1 with severe phenotype had a homozygous nonsense mutation in exon 1 (C-35 [RIGHTWARDS ARROW] T, Gln-3 [RIGHTWARDS ARROW] stop), patients 2 and 3 with mild phenotype shared the same homozygous missense mutation in exon 2 (G-98 [RIGHTWARDS ARROW] A, Gly-24 [RIGHTWARDS ARROW] Arg). None of the parents of patients 2 and 3 is related. Therefore, this mutation could be a hot-spot or a common mutation in the Japanese population. Patients 2 and 3, but not patient 1, were demonstrated to have detectable p22-phox expression and significant granulocyte respiratory burst (ROB) activity. In this study, we were able to demonstrate an excellent correlation between genotype, p22-phox expression, ROB activity and clinical phenotype in these patients.